Reducing the incidence of surgical site infection after ventral hernia repair: Outcomes from the RINSE randomized control trial.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
05 Jan 2024
Historique:
received: 27 11 2023
revised: 20 12 2023
accepted: 04 01 2024
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 10 1 2024
Statut: aheadofprint

Résumé

The clinical and financial impact of surgical site infection after ventral hernia repair is significant. Here we investigate the impact of dual antibiotic irrigation on SSI after VHR. This was a multicenter, prospective randomized control trial of open retromuscular VHR with mesh. Patients were randomized to gentamicin ​+ ​clindamycin (G ​+ ​C) (n ​= ​125) vs saline (n ​= ​125) irrigation at time of mesh placement. Primary outcome was 30-day SSI. No significant difference was seen in SSI between control and antibiotic irrigation (9.91 vs 9.09 ​%; p ​= ​0.836). No differences were seen in secondary outcomes: SSO (11.71 vs 13.64 ​%; p ​= ​0.667); 90-day SSO (11.1 vs 13.9 ​%; p ​= ​0.603); 90-day SSI (6.9 vs 3.8 ​%; p ​= ​0.389); SSIPI (7.21 vs 7.27 ​%, p ​= ​0.985); SSOPI (3.6 vs 3.64 ​%; p ​= ​0.990); 30-day readmission (9.91 vs 6.36 ​%; p ​= ​0.335); reoperation (5.41 vs 0.91 ​%; p ​= ​0.056). Dual antibiotic irrigation with G ​+ ​C did not reduce the risk of surgical site infection during open retromuscular ventral hernia repair.

Sections du résumé

BACKGROUND BACKGROUND
The clinical and financial impact of surgical site infection after ventral hernia repair is significant. Here we investigate the impact of dual antibiotic irrigation on SSI after VHR.
METHODS METHODS
This was a multicenter, prospective randomized control trial of open retromuscular VHR with mesh. Patients were randomized to gentamicin ​+ ​clindamycin (G ​+ ​C) (n ​= ​125) vs saline (n ​= ​125) irrigation at time of mesh placement. Primary outcome was 30-day SSI.
RESULTS RESULTS
No significant difference was seen in SSI between control and antibiotic irrigation (9.91 vs 9.09 ​%; p ​= ​0.836). No differences were seen in secondary outcomes: SSO (11.71 vs 13.64 ​%; p ​= ​0.667); 90-day SSO (11.1 vs 13.9 ​%; p ​= ​0.603); 90-day SSI (6.9 vs 3.8 ​%; p ​= ​0.389); SSIPI (7.21 vs 7.27 ​%, p ​= ​0.985); SSOPI (3.6 vs 3.64 ​%; p ​= ​0.990); 30-day readmission (9.91 vs 6.36 ​%; p ​= ​0.335); reoperation (5.41 vs 0.91 ​%; p ​= ​0.056).
CONCLUSION CONCLUSIONS
Dual antibiotic irrigation with G ​+ ​C did not reduce the risk of surgical site infection during open retromuscular ventral hernia repair.

Identifiants

pubmed: 38199871
pii: S0002-9610(24)00006-0
doi: 10.1016/j.amjsurg.2024.01.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The following authors have outside financial interests: Intuitive (Warren, Beffa, Prabhu, Nikolian, Pauli, Carbonell), Johnson and Johnson/Ethicon (Warren), Surgimatrix (Petro, Prabhu), Bard-Davol (Petro, Horne, Poulose), Advanced Medical Solutions Group (Petro, Poulose), CMR Surgical (Prabhu), Abdominal Core Health Quality Collaborative (Rosen, Poulose), Ariste Medical (Rosen), Medtronic (Nikolian, Pauli, Carbonell), Caresyntax (Nikolian), Beckton-Dickson (Pauli), Boston Scientific (Pauli), Actuated Medical (Pauli), Cook Biotech (Pauli), Neptune Medical (Pauli), Noah Medical (Pauli), Allergan (Pauli), ERBE (Pauli), Integra (Pauli), Steris (Pauli), Vicarious (Pauli), UpToDate (Pauli), Springer (Pauli), Deep Blue Medical Advances (Carbonell). The authors used no AI or AI assisted technologies in the writing process. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Auteurs

Jeremy A Warren (JA)

University of South Carolina School of Medicine Greenville and Prisma Health Upstate Department of Surgery, Greenville, SC, USA. Electronic address: Jeremy.warren@prismahealth.org.

Claiborne Lucas (C)

Prisma Health Upstate Department of Surgery, Greenville, SC, USA.

Lucas R Beffa (LR)

The Cleveland Clinic Foundation, Cleveland, OH, USA.

Clayton C Petro (CC)

The Cleveland Clinic Foundation, Cleveland, OH, USA.

Ajita S Prabhu (AS)

The Cleveland Clinic Foundation, Cleveland, OH, USA.

David M Krpata (DM)

The Cleveland Clinic Foundation, Cleveland, OH, USA.

Michael J Rosen (MJ)

The Cleveland Clinic Foundation, Cleveland, OH, USA.

Sean B Orenstein (SB)

Oregon Health & Science University, Portland, OR, USA.

Vahagn C Nikolian (VC)

Oregon Health & Science University, Portland, OR, USA.

Eric M Pauli (EM)

Penn State Health Milton S Hershey Medical Center Department of Surgery, Hershey, PA, USA.

Charlotte M Horne (CM)

Penn State Health Milton S Hershey Medical Center Department of Surgery, Hershey, PA, USA.

Molly LaBelle (M)

Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.

Sharon Phillips (S)

Vanderbilt University Medical Center, USA.

Benjamin K Poulose (BK)

The Ohio State University Wexner Department of Surgery and Center for Abdominal Core Health, Columbus, OH, USA.

Alfredo M Carbonell (AM)

University of South Carolina School of Medicine Greenville and Prisma Health Upstate Department of Surgery, Greenville, SC, USA.

Classifications MeSH